Home > Boards > US Listed > Biotechs > Marker Therapeutics Inc (MRKR)

In all the hundred or so companies I

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
apostrophe Member Profile
 
Followed By 19
Posts 1,084
Boards Moderated 0
Alias Born 10/17/06
160x600 placeholder
Marker Therapeutics Shares Rise Premarket on Key FDA Designation Dow Jones News - 1/20/2022 6:51:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/20/2022 6:00:59 AM
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer GlobeNewswire Inc. - 1/19/2022 4:49:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/9/2021 5:19:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2021 8:02:26 AM
Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors PR Newswire (US) - 12/9/2021 7:00:00 AM
Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting PR Newswire (US) - 11/18/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 7:11:46 AM
Marker Therapeutics EPS misses by $0.02 Seeking Alpha - 11/10/2021 4:38:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 4:11:12 PM
Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results PR Newswire (US) - 11/10/2021 4:05:00 PM
Marker Therapeutics to Present at Three Upcoming September Investor Conferences PR Newswire (US) - 9/7/2021 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/20/2021 6:03:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2021 4:13:47 PM
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas PR Newswire (US) - 8/19/2021 4:05:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/10/2021 5:11:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2021 4:03:08 PM
Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results PR Newswire (US) - 8/10/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2021 4:36:58 PM
Marker Therapeutics opens new cGMP manufacturing facility in Houston Seeking Alpha - 7/28/2021 4:13:52 PM
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility PR Newswire (US) - 7/28/2021 4:05:00 PM
Marker Therapeutics completes safety lead-in portion of mid-stage leukemia study Seeking Alpha - 7/6/2021 7:50:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 7:24:18 AM
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML PR Newswire (US) - 7/6/2021 7:00:00 AM
Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference PR Newswire (US) - 6/16/2021 4:05:00 PM
apostrophe   Tuesday, 01/19/16 05:09:24 AM
Re: tpizzazz24 post# 12258
Post # of 31753 
In all the hundred or so companies I have traded or invested in over the years, I have never got an unsolicited call from an IR person or someone claiming to be. That's not how it works. You call them, they call back. Same with email. This is highly irregular and feels phony.

I would contact TapImmune directly and ask about what's going on with this.

Sounds like a scam. Or setting up for some kind of scam.

Pre-revenue bio-techs on the verge of good news seem to be targets for bogus lawsuits and share price shorting attacks.

We may need to brace ourselves for some hedge fund mischief.





Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences